| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e5c121269689cbab9b3a4548b15caf3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2835 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-582
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6845 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2020-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73a46c293165968e26c2c0cb7ebcd7a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e3304250384ac88a84171d958315dc5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_093cd1b43dcdcb6628dcc6e2c90fd3b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e00d5aaf3e7d96b38ef6103da7c2d710
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b1ec5292c5f0500f2927be30cbc217a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bf38524240de8a7c432da1c2ef87fa7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05d49c7a23cea52de1ee2fcd73893bdd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0cfe9708a449d6ddd215462cb41d0b7a |
| publicationDate |
2021-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3922723-A1 |
| titleOfInvention |
Method and kit for discriminating between parkinson's disease and multiple system atrophy |
| abstract |
A method for discriminating between Parkinson's disease and multiple system atrophy, the method comprising the steps of: (1) preparing a solution containing α-synuclein monomers having a tendency to produce rod-like aggregates and/or a solution containing α-synuclein monomers having a tendency to produce twisted aggregates; (2) adding a biological sample from a subject to the solution (s) containing the α-synuclein monomers prepared in step (1); (3) allowing the α-synuclein monomers to aggregate in the solution(s) obtained in step (2); and (4) detecting α-synuclein aggregates formed in step (3). |
| priorityDate |
2019-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |